Steroid use in critically ill septic patients: Acknowledging the uncertainty

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 11, 2009, Pages 694-696

  Jaeschke, Roman ^a,b   Guyatt, Gordon ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Polish Institute of Evidence Based Medicine   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLOPIDOGREL; CORTICOSTEROID; HYDROCORTISONE; HYPERTENSIVE FACTOR; METHYLPREDNISOLONE; PROTON PUMP INHIBITOR;

ASTHMA; CLINICAL RESEARCH; CLINICAL TRIAL; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; DATA ANALYSIS; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; EDITORIAL; FLUID RESUSCITATION; HUMAN; LOW DRUG DOSE; METHODOLOGY; MORTALITY; PRACTICE GUIDELINE; RISK BENEFIT ANALYSIS; SEPTIC SHOCK; TREATMENT RESPONSE;

EID: 72149114576     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.811     Document Type: Editorial

References (11)

1. Cronin L, Cook DJ, Cartlet J, et al. Corticosteroids treatment for sep-sis: a critical appraisal and meta-analysis of the literature. Crit Care Med. 1995; 23: 1430-1439.
2. Bollaert PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998; 26: 645-650. (Pubitemid 28201409)
3. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002; 288: 862-871. (Pubitemid 34898534)
4. Sprung CL, Annane D, Keh D, et al; CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008; 358: 111-124.
5. Dellinger RP Levy MM, Carlet JM, et al; International Surviving Sepsis Campaign Guidelines Committee. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36: 296-327.
6. Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults. A systematic review. JAMA. 2009; 301: 2962-12375
7. Guyatt G, Wyer P, loannidis J. When to believe a subgroup analysis. In: Guyatt G, Rennie D, Meade M, Cook D, eds. Users' guides to the medical literature: a manual for evidence-based clinical practice. McGraw Hill; 2008.
8. Hirsh J, Guyatt G. Clinical experts or methodologists to write clinical guidelines? Lancet. 2009; 374: 273-275.
9. Drazen JM, O'Byme PM. Risks of long-acting beta-agonists in achieving asthma control. N Engl J Med. 2009; 360: 1671-1672.
10. Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009; 180: 713-718.
11. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336: 924-926.